# FDA recall D-0235-2022

> **Teva Pharmaceuticals USA** · Class III · drug recall initiated 2021-10-28.

## Product

Clonidine Transdermal System, USP 0.1 mg/day, 4 patches per carton, Rx only, Manufactured by: Actavis Laboratories, UT Inc., Salt Lake City, UT, Distributed by: Actavis Pharma, Inc., Parsippany, NJ NDC 0591-3508-04

## Reason for recall

Failed Impurities/Degradation Specifications

## Distribution

Nationwide and Puerto Rico

## Key facts

- **Recall number:** D-0235-2022
- **Recalling firm:** Teva Pharmaceuticals USA
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2021-10-28
- **Report date:** 2021-11-24
- **Termination date:** 2023-02-27

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Parsippany, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0235-2022

## Citation

> AI Analytics. FDA recall D-0235-2022. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-0235-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*